Abiomed (NSDQ:ABMD) said this week it inked a deal to purchase its existing corporate headquarters in Danvers, Mass. for $16.5 million.
The company said that it opted to buy the facilities, which includes 12 acres of land and all associated buildings, structures and other improvements, through an option in its existing lease with the original owners.
Abiomed said it hopes that the purchase will close by October 30, according to an SEC filing.
In early August, Abiomed saw shares rise 3.2% after the Centers for Medicaid & Medicare Services announced a lower-than-expected cut to the reimbursement rate for intensive care unit procedures using its Impella heart pump.
